These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11750440)

  • 1. Is losartan as effective as enalapril on posttransplant persistent proteinuria?
    Altiparmak MR; Trablus S; Apaydin S; Başar O; Sariyar M; Serdengeçti K; Erek E
    Transplant Proc; 2001; 33(7-8):3368-9. PubMed ID: 11750440
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract]   [Full Text] [Related]  

  • 3. Losartan reduces massive proteinuria in kidney transplant patients: a pilot study.
    Domínguez-Gil B; Ortiz M; Sierra MP; Muñoz MA; Morales E; Andres A; Rodicio JL; Morales JM
    Transplant Proc; 2002 Feb; 34(1):368-9. PubMed ID: 11959331
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of losartan in renal transplant recipients.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1999 Dec; 31(8):3300-1. PubMed ID: 10616484
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
    Holgado R; Anaya F; Del Castillo D
    Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of severe proteinuria with losartan after renal transplantation.
    Navarro JF; Macía ML; García J
    Am J Nephrol; 1998; 18(3):261-2. PubMed ID: 9627049
    [No Abstract]   [Full Text] [Related]  

  • 8. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL; Nicolay K; Koomans HA; Joles JA
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension.
    Calviño J; Lens XM; Romero R; Sánchez-Guisande D
    Nephrol Dial Transplant; 2000 Jan; 15(1):82-6. PubMed ID: 10607772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
    Bryant CE; Rajai A; Webb NJA; Hogg RJ
    Pediatr Nephrol; 2021 Oct; 36(10):3211-3219. PubMed ID: 33881639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.
    Hoque R; Rahman MS; Iqbal M
    Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):44-8. PubMed ID: 20120778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPARISON OF LOSARTAN AND ENALAPRIL EFFECTS ON RENAL FUNCTION IN HYPERTENSIVE ADULTS WITH CHRONIC KIDNEY DISEASE AT A KENYAN REFERRAL HOSPITAL.
    Mugendi GA; Nyamu DG; Okalebo FA; Nyamweya NN; Ndwiga S; Mwangi M
    East Afr Med J; 2014 Apr; 91(4):125-32. PubMed ID: 26859031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H; Baskın E; Bayrakcı US; Moray G; Haberal M
    Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
    Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan and renal transplantation.
    Aurup P; Smith RD
    Lancet; 1998 Mar; 351(9107):990. PubMed ID: 9734972
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
    Neki NS; Arora P
    J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.